| Literature DB >> 9024742 |
Abstract
The role of adenosine triphosphate-sensitive potassium channels in the adaptive response to demand ischemia was tested in 22 patients treated with placebo or glibenclamide before sequential exercise testing or atrial pacing. Glibenclamide did not affect the improvement in signs of ischemia in both protocols, indicating that opening of these channels is not a mechanism of this adaptive response in humans.Entities:
Mesh：
Substances：
Year: 1997 PMID： 9024742 DOI： 10.1016/s0002-9149(96)00681-9
Source DB: PubMed Journal: Am J Cardiol ISSN： 0002-9149 Impact factor: 2.778